The effect of low and high dose empagliflozin on HbA1c and lipid profile in type 2 diabetes mellitus: A real-world data
OBJECTIVE: This study aims to evaluate the efficacy and safety of the addition of 10 or 25 mg of empagliflozin to patients with type 2 diabetes mellitus using a maximum tolerable dose of metformin and gliclazide. METHODS: A total of 60 patients who had been receiving a maximum tolerable dose of metf...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
KARE Publishing
2020-03-01
|
Series: | İstanbul Kuzey Klinikleri |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=nci&un=NCI-22697 |